SP Accure Labs, a Hyderabad-based pharma company, has launched an alternative drug Amphotericin-B-Emulation for treatment of Mucormycosis, the fungal infection better known as black fungus.
The growing incidence of black fungus infection is the latest health worry for the nation grappling with the second wave of Covid-19.
This new drug will be offered in the market within a week at 5,400 per unit.
P Girish Bhat, Managing Director, Medihauxe Pharma said Currently we have 10,000 vials of the medicine…
Which Memory Stock Is Better Suited for Long-Term Holding, MU or SNDK?
September 20, 2026
